National Academies report recommends greater transparency, collaboration between regulatory agencies

A report by the National Academies of Sciences, Engineering and Medicine recommends that FDA, EMA and other drug regulatory agencies tear down walls that limit information sharing and increase collaboration in order to avoid redundant regulatory activities that can delay patients' access to new drugs.

The report asserts that it is "imperative" for regulatory agencies to "find ways to continue or expand upon their ability and willingness to work together to maximize the use of their finite resources so they can ensure the quality, safety, efficacy and availability of medicines for their jurisdictions in both emergency and non-emergent situations."...